nodes	percent_of_prediction	percent_of_DWPC	metapath
Bupivacaine—CYP2C19—Sorafenib—liver cancer	0.116	0.255	CbGbCtD
Bupivacaine—CYP1A2—Sorafenib—liver cancer	0.107	0.235	CbGbCtD
Bupivacaine—CYP2D6—Sorafenib—liver cancer	0.088	0.194	CbGbCtD
Bupivacaine—CYP3A4—Sorafenib—liver cancer	0.0559	0.123	CbGbCtD
Bupivacaine—CYP2D6—Doxorubicin—liver cancer	0.0534	0.118	CbGbCtD
Bupivacaine—CYP3A4—Doxorubicin—liver cancer	0.0339	0.0748	CbGbCtD
Bupivacaine—Infestation—Sorafenib—liver cancer	0.00229	0.00708	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Sorafenib—liver cancer	0.00225	0.00694	CcSEcCtD
Bupivacaine—Hypokinesia—Epirubicin—liver cancer	0.00224	0.00693	CcSEcCtD
Bupivacaine—Paralysis—Epirubicin—liver cancer	0.00218	0.00673	CcSEcCtD
Bupivacaine—Ileus—Epirubicin—liver cancer	0.00214	0.00661	CcSEcCtD
Bupivacaine—Hypokinesia—Doxorubicin—liver cancer	0.00208	0.00641	CcSEcCtD
Bupivacaine—Ventricular arrhythmia—Epirubicin—liver cancer	0.00205	0.00632	CcSEcCtD
Bupivacaine—Paralysis—Doxorubicin—liver cancer	0.00202	0.00623	CcSEcCtD
Bupivacaine—Ileus—Doxorubicin—liver cancer	0.00198	0.00611	CcSEcCtD
Bupivacaine—Fungal infection—Epirubicin—liver cancer	0.00196	0.00606	CcSEcCtD
Bupivacaine—Feeling hot—Epirubicin—liver cancer	0.00193	0.00596	CcSEcCtD
Bupivacaine—Tinnitus—Sorafenib—liver cancer	0.00192	0.00592	CcSEcCtD
Bupivacaine—Flushing—Sorafenib—liver cancer	0.00191	0.0059	CcSEcCtD
Bupivacaine—Cardiac disorder—Sorafenib—liver cancer	0.00191	0.0059	CcSEcCtD
Bupivacaine—Ventricular arrhythmia—Doxorubicin—liver cancer	0.00189	0.00585	CcSEcCtD
Bupivacaine—Rigors—Epirubicin—liver cancer	0.00185	0.00573	CcSEcCtD
Bupivacaine—Arrhythmia—Sorafenib—liver cancer	0.00184	0.00568	CcSEcCtD
Bupivacaine—Fungal infection—Doxorubicin—liver cancer	0.00181	0.0056	CcSEcCtD
Bupivacaine—Mental disorder—Sorafenib—liver cancer	0.0018	0.00557	CcSEcCtD
Bupivacaine—Malnutrition—Sorafenib—liver cancer	0.00179	0.00553	CcSEcCtD
Bupivacaine—Erythema—Sorafenib—liver cancer	0.00179	0.00553	CcSEcCtD
Bupivacaine—Feeling hot—Doxorubicin—liver cancer	0.00178	0.00551	CcSEcCtD
Bupivacaine—Breast pain—Epirubicin—liver cancer	0.00174	0.00536	CcSEcCtD
Bupivacaine—Extravasation—Epirubicin—liver cancer	0.00174	0.00536	CcSEcCtD
Bupivacaine—Cardiovascular disorder—Epirubicin—liver cancer	0.00172	0.00532	CcSEcCtD
Bupivacaine—Muscle spasms—Sorafenib—liver cancer	0.00172	0.00532	CcSEcCtD
Bupivacaine—Rigors—Doxorubicin—liver cancer	0.00172	0.0053	CcSEcCtD
Bupivacaine—Bone disorder—Epirubicin—liver cancer	0.00168	0.00518	CcSEcCtD
Bupivacaine—Skin discolouration—Epirubicin—liver cancer	0.00168	0.00518	CcSEcCtD
Bupivacaine—Ventricular extrasystoles—Epirubicin—liver cancer	0.00168	0.00518	CcSEcCtD
Bupivacaine—Anaemia—Sorafenib—liver cancer	0.00166	0.00511	CcSEcCtD
Bupivacaine—Hypocalcaemia—Epirubicin—liver cancer	0.00165	0.00511	CcSEcCtD
Bupivacaine—Angioedema—Sorafenib—liver cancer	0.00164	0.00505	CcSEcCtD
Bupivacaine—Syncope—Sorafenib—liver cancer	0.00161	0.00496	CcSEcCtD
Bupivacaine—Breast pain—Doxorubicin—liver cancer	0.00161	0.00496	CcSEcCtD
Bupivacaine—Extravasation—Doxorubicin—liver cancer	0.00161	0.00496	CcSEcCtD
Bupivacaine—Dysarthria—Epirubicin—liver cancer	0.0016	0.00494	CcSEcCtD
Bupivacaine—Blood bilirubin increased—Epirubicin—liver cancer	0.0016	0.00494	CcSEcCtD
Bupivacaine—Cardiovascular disorder—Doxorubicin—liver cancer	0.00159	0.00492	CcSEcCtD
Bupivacaine—Loss of consciousness—Sorafenib—liver cancer	0.00157	0.00486	CcSEcCtD
Bupivacaine—Cough—Sorafenib—liver cancer	0.00156	0.00483	CcSEcCtD
Bupivacaine—Atrioventricular block—Epirubicin—liver cancer	0.00156	0.00482	CcSEcCtD
Bupivacaine—Skin discolouration—Doxorubicin—liver cancer	0.00155	0.00479	CcSEcCtD
Bupivacaine—Bone disorder—Doxorubicin—liver cancer	0.00155	0.00479	CcSEcCtD
Bupivacaine—Ventricular extrasystoles—Doxorubicin—liver cancer	0.00155	0.00479	CcSEcCtD
Bupivacaine—Hypertension—Sorafenib—liver cancer	0.00155	0.00478	CcSEcCtD
Bupivacaine—Neck pain—Epirubicin—liver cancer	0.00153	0.00473	CcSEcCtD
Bupivacaine—Hypocalcaemia—Doxorubicin—liver cancer	0.00153	0.00473	CcSEcCtD
Bupivacaine—Arthralgia—Sorafenib—liver cancer	0.00152	0.00471	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—liver cancer	0.00151	0.00468	CcSEcCtD
Bupivacaine—Ventricular tachycardia—Epirubicin—liver cancer	0.00151	0.00468	CcSEcCtD
Bupivacaine—Hyperkalaemia—Epirubicin—liver cancer	0.00149	0.00459	CcSEcCtD
Bupivacaine—Dysarthria—Doxorubicin—liver cancer	0.00148	0.00457	CcSEcCtD
Bupivacaine—Blood bilirubin increased—Doxorubicin—liver cancer	0.00148	0.00457	CcSEcCtD
Bupivacaine—Anaphylactic shock—Sorafenib—liver cancer	0.00146	0.00451	CcSEcCtD
Bupivacaine—Infection—Sorafenib—liver cancer	0.00145	0.00448	CcSEcCtD
Bupivacaine—Atrioventricular block—Doxorubicin—liver cancer	0.00144	0.00446	CcSEcCtD
Bupivacaine—Shock—Sorafenib—liver cancer	0.00144	0.00444	CcSEcCtD
Bupivacaine—Nervous system disorder—Sorafenib—liver cancer	0.00143	0.00443	CcSEcCtD
Bupivacaine—Neuropathy—Epirubicin—liver cancer	0.00142	0.00439	CcSEcCtD
Bupivacaine—Skin disorder—Sorafenib—liver cancer	0.00142	0.00438	CcSEcCtD
Bupivacaine—Neck pain—Doxorubicin—liver cancer	0.00142	0.00438	CcSEcCtD
Bupivacaine—Ventricular tachycardia—Doxorubicin—liver cancer	0.0014	0.00433	CcSEcCtD
Bupivacaine—Hyperkalaemia—Doxorubicin—liver cancer	0.00138	0.00425	CcSEcCtD
Bupivacaine—Pulmonary oedema—Epirubicin—liver cancer	0.00135	0.00416	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00133	0.00411	CcSEcCtD
Bupivacaine—Neuropathy—Doxorubicin—liver cancer	0.00132	0.00406	CcSEcCtD
Bupivacaine—Dyspnoea—Sorafenib—liver cancer	0.0013	0.00402	CcSEcCtD
Bupivacaine—Dyspepsia—Sorafenib—liver cancer	0.00129	0.00397	CcSEcCtD
Bupivacaine—Decreased appetite—Sorafenib—liver cancer	0.00127	0.00392	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Sorafenib—liver cancer	0.00126	0.0039	CcSEcCtD
Bupivacaine—Pain—Sorafenib—liver cancer	0.00125	0.00386	CcSEcCtD
Bupivacaine—Constipation—Sorafenib—liver cancer	0.00125	0.00386	CcSEcCtD
Bupivacaine—Pulmonary oedema—Doxorubicin—liver cancer	0.00125	0.00385	CcSEcCtD
Bupivacaine—Vascular purpura—Epirubicin—liver cancer	0.00123	0.00379	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Sorafenib—liver cancer	0.0012	0.00369	CcSEcCtD
Bupivacaine—Urticaria—Sorafenib—liver cancer	0.00116	0.00359	CcSEcCtD
Bupivacaine—Body temperature increased—Sorafenib—liver cancer	0.00116	0.00357	CcSEcCtD
Bupivacaine—Abdominal pain—Sorafenib—liver cancer	0.00116	0.00357	CcSEcCtD
Bupivacaine—Purpura—Epirubicin—liver cancer	0.00114	0.00352	CcSEcCtD
Bupivacaine—Vascular purpura—Doxorubicin—liver cancer	0.00114	0.00351	CcSEcCtD
Bupivacaine—Anaphylactoid reaction—Epirubicin—liver cancer	0.00114	0.00351	CcSEcCtD
Bupivacaine—Lethargy—Epirubicin—liver cancer	0.00112	0.00346	CcSEcCtD
Bupivacaine—Osteoarthritis—Epirubicin—liver cancer	0.0011	0.00339	CcSEcCtD
Bupivacaine—Diplopia—Epirubicin—liver cancer	0.0011	0.00339	CcSEcCtD
Bupivacaine—Hypersensitivity—Sorafenib—liver cancer	0.00108	0.00333	CcSEcCtD
Bupivacaine—Purpura—Doxorubicin—liver cancer	0.00105	0.00326	CcSEcCtD
Bupivacaine—Anaphylactoid reaction—Doxorubicin—liver cancer	0.00105	0.00324	CcSEcCtD
Bupivacaine—Asthenia—Sorafenib—liver cancer	0.00105	0.00324	CcSEcCtD
Bupivacaine—Cardiac arrest—Epirubicin—liver cancer	0.00104	0.00323	CcSEcCtD
Bupivacaine—Lethargy—Doxorubicin—liver cancer	0.00104	0.0032	CcSEcCtD
Bupivacaine—Pruritus—Sorafenib—liver cancer	0.00103	0.00319	CcSEcCtD
Bupivacaine—Blood creatinine increased—Epirubicin—liver cancer	0.00103	0.00318	CcSEcCtD
Bupivacaine—Osteoarthritis—Doxorubicin—liver cancer	0.00102	0.00314	CcSEcCtD
Bupivacaine—Diplopia—Doxorubicin—liver cancer	0.00102	0.00314	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Epirubicin—liver cancer	0.001	0.0031	CcSEcCtD
Bupivacaine—Diarrhoea—Sorafenib—liver cancer	0.001	0.00309	CcSEcCtD
Bupivacaine—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00099	0.00306	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Epirubicin—liver cancer	0.000969	0.00299	CcSEcCtD
Bupivacaine—Muscular weakness—Epirubicin—liver cancer	0.000969	0.00299	CcSEcCtD
Bupivacaine—Cardiac arrest—Doxorubicin—liver cancer	0.000967	0.00299	CcSEcCtD
Bupivacaine—Dizziness—Sorafenib—liver cancer	0.000966	0.00299	CcSEcCtD
Bupivacaine—Abdominal distension—Epirubicin—liver cancer	0.000956	0.00295	CcSEcCtD
Bupivacaine—Blood creatinine increased—Doxorubicin—liver cancer	0.000953	0.00294	CcSEcCtD
Bupivacaine—Dysphagia—Epirubicin—liver cancer	0.00095	0.00293	CcSEcCtD
Bupivacaine—Vomiting—Sorafenib—liver cancer	0.000929	0.00287	CcSEcCtD
Bupivacaine—Orthostatic hypotension—Doxorubicin—liver cancer	0.000929	0.00287	CcSEcCtD
Bupivacaine—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.000916	0.00283	CcSEcCtD
Bupivacaine—Headache—Sorafenib—liver cancer	0.000916	0.00283	CcSEcCtD
Bupivacaine—Muscular weakness—Doxorubicin—liver cancer	0.000897	0.00277	CcSEcCtD
Bupivacaine—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.000897	0.00277	CcSEcCtD
Bupivacaine—Abdominal distension—Doxorubicin—liver cancer	0.000885	0.00273	CcSEcCtD
Bupivacaine—Dysphagia—Doxorubicin—liver cancer	0.000879	0.00271	CcSEcCtD
Bupivacaine—Nausea—Sorafenib—liver cancer	0.000868	0.00268	CcSEcCtD
Bupivacaine—Infestation NOS—Epirubicin—liver cancer	0.000847	0.00262	CcSEcCtD
Bupivacaine—Drowsiness—Epirubicin—liver cancer	0.000847	0.00262	CcSEcCtD
Bupivacaine—Infestation—Epirubicin—liver cancer	0.000847	0.00262	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Epirubicin—liver cancer	0.00083	0.00256	CcSEcCtD
Bupivacaine—Urinary tract infection—Epirubicin—liver cancer	0.000823	0.00254	CcSEcCtD
Bupivacaine—Sweating—Epirubicin—liver cancer	0.000812	0.00251	CcSEcCtD
Bupivacaine—Haematuria—Epirubicin—liver cancer	0.000807	0.00249	CcSEcCtD
Bupivacaine—Drowsiness—Doxorubicin—liver cancer	0.000784	0.00242	CcSEcCtD
Bupivacaine—Infestation NOS—Doxorubicin—liver cancer	0.000784	0.00242	CcSEcCtD
Bupivacaine—Infestation—Doxorubicin—liver cancer	0.000784	0.00242	CcSEcCtD
Bupivacaine—Bradycardia—Epirubicin—liver cancer	0.000774	0.00239	CcSEcCtD
Bupivacaine—Neuropathy peripheral—Doxorubicin—liver cancer	0.000768	0.00237	CcSEcCtD
Bupivacaine—Urinary tract infection—Doxorubicin—liver cancer	0.000762	0.00235	CcSEcCtD
Bupivacaine—Hypoaesthesia—Epirubicin—liver cancer	0.000756	0.00234	CcSEcCtD
Bupivacaine—Sweating—Doxorubicin—liver cancer	0.000751	0.00232	CcSEcCtD
Bupivacaine—Oedema peripheral—Epirubicin—liver cancer	0.000749	0.00231	CcSEcCtD
Bupivacaine—Haematuria—Doxorubicin—liver cancer	0.000747	0.00231	CcSEcCtD
Bupivacaine—Bradycardia—Doxorubicin—liver cancer	0.000716	0.00221	CcSEcCtD
Bupivacaine—Tinnitus—Epirubicin—liver cancer	0.000709	0.00219	CcSEcCtD
Bupivacaine—Flushing—Epirubicin—liver cancer	0.000706	0.00218	CcSEcCtD
Bupivacaine—Cardiac disorder—Epirubicin—liver cancer	0.000706	0.00218	CcSEcCtD
Bupivacaine—Hypoaesthesia—Doxorubicin—liver cancer	0.0007	0.00216	CcSEcCtD
Bupivacaine—Oedema peripheral—Doxorubicin—liver cancer	0.000693	0.00214	CcSEcCtD
Bupivacaine—Chills—Epirubicin—liver cancer	0.000682	0.00211	CcSEcCtD
Bupivacaine—Arrhythmia—Epirubicin—liver cancer	0.000679	0.0021	CcSEcCtD
Bupivacaine—Mental disorder—Epirubicin—liver cancer	0.000666	0.00206	CcSEcCtD
Bupivacaine—Erythema—Epirubicin—liver cancer	0.000662	0.00204	CcSEcCtD
Bupivacaine—Malnutrition—Epirubicin—liver cancer	0.000662	0.00204	CcSEcCtD
Bupivacaine—Tinnitus—Doxorubicin—liver cancer	0.000656	0.00203	CcSEcCtD
Bupivacaine—Cardiac disorder—Doxorubicin—liver cancer	0.000653	0.00202	CcSEcCtD
Bupivacaine—Flushing—Doxorubicin—liver cancer	0.000653	0.00202	CcSEcCtD
Bupivacaine—Flatulence—Epirubicin—liver cancer	0.000652	0.00201	CcSEcCtD
Bupivacaine—Tension—Epirubicin—liver cancer	0.000649	0.00201	CcSEcCtD
Bupivacaine—Nervousness—Epirubicin—liver cancer	0.000643	0.00199	CcSEcCtD
Bupivacaine—Back pain—Epirubicin—liver cancer	0.00064	0.00198	CcSEcCtD
Bupivacaine—Muscle spasms—Epirubicin—liver cancer	0.000636	0.00197	CcSEcCtD
Bupivacaine—Chills—Doxorubicin—liver cancer	0.000631	0.00195	CcSEcCtD
Bupivacaine—Arrhythmia—Doxorubicin—liver cancer	0.000628	0.00194	CcSEcCtD
Bupivacaine—Vision blurred—Epirubicin—liver cancer	0.000624	0.00193	CcSEcCtD
Bupivacaine—Mental disorder—Doxorubicin—liver cancer	0.000616	0.0019	CcSEcCtD
Bupivacaine—Erythema—Doxorubicin—liver cancer	0.000612	0.00189	CcSEcCtD
Bupivacaine—Malnutrition—Doxorubicin—liver cancer	0.000612	0.00189	CcSEcCtD
Bupivacaine—Anaemia—Epirubicin—liver cancer	0.000612	0.00189	CcSEcCtD
Bupivacaine—Agitation—Epirubicin—liver cancer	0.000608	0.00188	CcSEcCtD
Bupivacaine—Flatulence—Doxorubicin—liver cancer	0.000603	0.00186	CcSEcCtD
Bupivacaine—Tension—Doxorubicin—liver cancer	0.000601	0.00186	CcSEcCtD
Bupivacaine—Nervousness—Doxorubicin—liver cancer	0.000595	0.00184	CcSEcCtD
Bupivacaine—Syncope—Epirubicin—liver cancer	0.000593	0.00183	CcSEcCtD
Bupivacaine—Back pain—Doxorubicin—liver cancer	0.000592	0.00183	CcSEcCtD
Bupivacaine—Muscle spasms—Doxorubicin—liver cancer	0.000589	0.00182	CcSEcCtD
Bupivacaine—Palpitations—Epirubicin—liver cancer	0.000585	0.00181	CcSEcCtD
Bupivacaine—Loss of consciousness—Epirubicin—liver cancer	0.000582	0.0018	CcSEcCtD
Bupivacaine—Cough—Epirubicin—liver cancer	0.000578	0.00178	CcSEcCtD
Bupivacaine—Vision blurred—Doxorubicin—liver cancer	0.000577	0.00178	CcSEcCtD
Bupivacaine—Convulsion—Epirubicin—liver cancer	0.000573	0.00177	CcSEcCtD
Bupivacaine—Hypertension—Epirubicin—liver cancer	0.000571	0.00176	CcSEcCtD
Bupivacaine—Anaemia—Doxorubicin—liver cancer	0.000566	0.00175	CcSEcCtD
Bupivacaine—Arthralgia—Epirubicin—liver cancer	0.000563	0.00174	CcSEcCtD
Bupivacaine—Agitation—Doxorubicin—liver cancer	0.000563	0.00174	CcSEcCtD
Bupivacaine—Anxiety—Epirubicin—liver cancer	0.000561	0.00173	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—liver cancer	0.00056	0.00173	CcSEcCtD
Bupivacaine—Syncope—Doxorubicin—liver cancer	0.000549	0.0017	CcSEcCtD
Bupivacaine—Confusional state—Epirubicin—liver cancer	0.000545	0.00168	CcSEcCtD
Bupivacaine—Palpitations—Doxorubicin—liver cancer	0.000541	0.00167	CcSEcCtD
Bupivacaine—Oedema—Epirubicin—liver cancer	0.00054	0.00167	CcSEcCtD
Bupivacaine—Anaphylactic shock—Epirubicin—liver cancer	0.00054	0.00167	CcSEcCtD
Bupivacaine—Loss of consciousness—Doxorubicin—liver cancer	0.000538	0.00166	CcSEcCtD
Bupivacaine—Infection—Epirubicin—liver cancer	0.000537	0.00166	CcSEcCtD
Bupivacaine—Cough—Doxorubicin—liver cancer	0.000534	0.00165	CcSEcCtD
Bupivacaine—Shock—Epirubicin—liver cancer	0.000531	0.00164	CcSEcCtD
Bupivacaine—Convulsion—Doxorubicin—liver cancer	0.000531	0.00164	CcSEcCtD
Bupivacaine—Nervous system disorder—Epirubicin—liver cancer	0.00053	0.00164	CcSEcCtD
Bupivacaine—Hypertension—Doxorubicin—liver cancer	0.000529	0.00163	CcSEcCtD
Bupivacaine—Tachycardia—Epirubicin—liver cancer	0.000527	0.00163	CcSEcCtD
Bupivacaine—Skin disorder—Epirubicin—liver cancer	0.000525	0.00162	CcSEcCtD
Bupivacaine—Hyperhidrosis—Epirubicin—liver cancer	0.000522	0.00161	CcSEcCtD
Bupivacaine—Arthralgia—Doxorubicin—liver cancer	0.000521	0.00161	CcSEcCtD
Bupivacaine—Anxiety—Doxorubicin—liver cancer	0.00052	0.0016	CcSEcCtD
Bupivacaine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—liver cancer	0.000518	0.0016	CcSEcCtD
Bupivacaine—Hypotension—Epirubicin—liver cancer	0.000505	0.00156	CcSEcCtD
Bupivacaine—Confusional state—Doxorubicin—liver cancer	0.000504	0.00156	CcSEcCtD
Bupivacaine—Oedema—Doxorubicin—liver cancer	0.0005	0.00154	CcSEcCtD
Bupivacaine—Anaphylactic shock—Doxorubicin—liver cancer	0.0005	0.00154	CcSEcCtD
Bupivacaine—Infection—Doxorubicin—liver cancer	0.000497	0.00153	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Epirubicin—liver cancer	0.000492	0.00152	CcSEcCtD
Bupivacaine—Shock—Doxorubicin—liver cancer	0.000492	0.00152	CcSEcCtD
Bupivacaine—Nervous system disorder—Doxorubicin—liver cancer	0.00049	0.00151	CcSEcCtD
Bupivacaine—Insomnia—Epirubicin—liver cancer	0.000489	0.00151	CcSEcCtD
Bupivacaine—Tachycardia—Doxorubicin—liver cancer	0.000488	0.00151	CcSEcCtD
Bupivacaine—Skin disorder—Doxorubicin—liver cancer	0.000485	0.0015	CcSEcCtD
Bupivacaine—Paraesthesia—Epirubicin—liver cancer	0.000485	0.0015	CcSEcCtD
Bupivacaine—Hyperhidrosis—Doxorubicin—liver cancer	0.000483	0.00149	CcSEcCtD
Bupivacaine—Dyspnoea—Epirubicin—liver cancer	0.000482	0.00149	CcSEcCtD
Bupivacaine—Somnolence—Epirubicin—liver cancer	0.00048	0.00148	CcSEcCtD
Bupivacaine—Dyspepsia—Epirubicin—liver cancer	0.000475	0.00147	CcSEcCtD
Bupivacaine—Decreased appetite—Epirubicin—liver cancer	0.00047	0.00145	CcSEcCtD
Bupivacaine—Hypotension—Doxorubicin—liver cancer	0.000467	0.00144	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Epirubicin—liver cancer	0.000466	0.00144	CcSEcCtD
Bupivacaine—Constipation—Epirubicin—liver cancer	0.000462	0.00143	CcSEcCtD
Bupivacaine—Pain—Epirubicin—liver cancer	0.000462	0.00143	CcSEcCtD
Bupivacaine—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.000455	0.00141	CcSEcCtD
Bupivacaine—Insomnia—Doxorubicin—liver cancer	0.000452	0.0014	CcSEcCtD
Bupivacaine—Paraesthesia—Doxorubicin—liver cancer	0.000449	0.00139	CcSEcCtD
Bupivacaine—Dyspnoea—Doxorubicin—liver cancer	0.000446	0.00138	CcSEcCtD
Bupivacaine—Feeling abnormal—Epirubicin—liver cancer	0.000445	0.00137	CcSEcCtD
Bupivacaine—Somnolence—Doxorubicin—liver cancer	0.000444	0.00137	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Epirubicin—liver cancer	0.000442	0.00136	CcSEcCtD
Bupivacaine—Dyspepsia—Doxorubicin—liver cancer	0.00044	0.00136	CcSEcCtD
Bupivacaine—Decreased appetite—Doxorubicin—liver cancer	0.000434	0.00134	CcSEcCtD
Bupivacaine—Gastrointestinal disorder—Doxorubicin—liver cancer	0.000431	0.00133	CcSEcCtD
Bupivacaine—Urticaria—Epirubicin—liver cancer	0.000429	0.00133	CcSEcCtD
Bupivacaine—Constipation—Doxorubicin—liver cancer	0.000427	0.00132	CcSEcCtD
Bupivacaine—Pain—Doxorubicin—liver cancer	0.000427	0.00132	CcSEcCtD
Bupivacaine—Body temperature increased—Epirubicin—liver cancer	0.000427	0.00132	CcSEcCtD
Bupivacaine—Abdominal pain—Epirubicin—liver cancer	0.000427	0.00132	CcSEcCtD
Bupivacaine—Feeling abnormal—Doxorubicin—liver cancer	0.000412	0.00127	CcSEcCtD
Bupivacaine—Gastrointestinal pain—Doxorubicin—liver cancer	0.000409	0.00126	CcSEcCtD
Bupivacaine—Hypersensitivity—Epirubicin—liver cancer	0.000398	0.00123	CcSEcCtD
Bupivacaine—Urticaria—Doxorubicin—liver cancer	0.000397	0.00123	CcSEcCtD
Bupivacaine—Abdominal pain—Doxorubicin—liver cancer	0.000395	0.00122	CcSEcCtD
Bupivacaine—Body temperature increased—Doxorubicin—liver cancer	0.000395	0.00122	CcSEcCtD
Bupivacaine—Asthenia—Epirubicin—liver cancer	0.000388	0.0012	CcSEcCtD
Bupivacaine—Pruritus—Epirubicin—liver cancer	0.000382	0.00118	CcSEcCtD
Bupivacaine—Diarrhoea—Epirubicin—liver cancer	0.00037	0.00114	CcSEcCtD
Bupivacaine—Hypersensitivity—Doxorubicin—liver cancer	0.000368	0.00114	CcSEcCtD
Bupivacaine—Asthenia—Doxorubicin—liver cancer	0.000359	0.00111	CcSEcCtD
Bupivacaine—Dizziness—Epirubicin—liver cancer	0.000357	0.0011	CcSEcCtD
Bupivacaine—Pruritus—Doxorubicin—liver cancer	0.000354	0.00109	CcSEcCtD
Bupivacaine—Vomiting—Epirubicin—liver cancer	0.000343	0.00106	CcSEcCtD
Bupivacaine—Diarrhoea—Doxorubicin—liver cancer	0.000342	0.00106	CcSEcCtD
Bupivacaine—Headache—Epirubicin—liver cancer	0.000338	0.00105	CcSEcCtD
Bupivacaine—Dizziness—Doxorubicin—liver cancer	0.00033	0.00102	CcSEcCtD
Bupivacaine—Nausea—Epirubicin—liver cancer	0.000321	0.000991	CcSEcCtD
Bupivacaine—Vomiting—Doxorubicin—liver cancer	0.000318	0.000981	CcSEcCtD
Bupivacaine—Headache—Doxorubicin—liver cancer	0.000313	0.000967	CcSEcCtD
Bupivacaine—Nausea—Doxorubicin—liver cancer	0.000297	0.000917	CcSEcCtD
Bupivacaine—CYP1A2—Biological oxidations—GSTP1—liver cancer	0.000157	0.000708	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—liver cancer	0.000157	0.000705	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—HRAS—liver cancer	0.000156	0.000703	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—GSTP1—liver cancer	0.000155	0.000698	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—VEGFA—liver cancer	0.000154	0.000694	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—STAT3—liver cancer	0.000153	0.000687	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PIK3CG—liver cancer	0.000152	0.000682	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—HRAS—liver cancer	0.000151	0.000678	CbGpPWpGaD
Bupivacaine—SCN4A—Axon guidance—IL6—liver cancer	0.00015	0.000673	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—VEGFA—liver cancer	0.000149	0.000669	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—STAT3—liver cancer	0.000147	0.000663	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000147	0.000662	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000145	0.000653	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—GSTM1—liver cancer	0.000145	0.00065	CbGpPWpGaD
Bupivacaine—SCN10A—Axon guidance—IL6—liver cancer	0.000144	0.000649	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—F2—liver cancer	0.000144	0.000647	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—GSTM1—liver cancer	0.000143	0.000641	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—TGFB1—liver cancer	0.000142	0.000637	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.00014	0.000627	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PIK3CG—liver cancer	0.000138	0.00062	CbGpPWpGaD
Bupivacaine—CYP1A2—Biological oxidations—CYP1A1—liver cancer	0.000137	0.000616	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—TGFB1—liver cancer	0.000137	0.000614	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000135	0.000608	CbGpPWpGaD
Bupivacaine—CYP1A2—Metapathway biotransformation—CYP1A1—liver cancer	0.000135	0.000608	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.000135	0.000605	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PIK3CD—liver cancer	0.000133	0.0006	CbGpPWpGaD
Bupivacaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—liver cancer	0.000133	0.000599	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—TNF—liver cancer	0.000132	0.000595	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000132	0.000593	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—UGDH—liver cancer	0.000132	0.000592	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—KRAS—liver cancer	0.000131	0.00059	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—TNF—liver cancer	0.000128	0.000574	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—KRAS—liver cancer	0.000127	0.000569	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—EPT1—liver cancer	0.000124	0.000556	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PRKCE—liver cancer	0.000123	0.000551	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000122	0.000546	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PIK3CD—liver cancer	0.000121	0.000545	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—UGDH—liver cancer	0.000121	0.000544	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.00012	0.000539	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—TAT—liver cancer	0.000117	0.000527	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PIK3CB—liver cancer	0.000116	0.000523	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IGF2—liver cancer	0.000116	0.000522	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000115	0.000519	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—EPT1—liver cancer	0.000114	0.000512	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000112	0.000502	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—HRAS—liver cancer	0.000112	0.000502	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.00011	0.000495	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CSF2—liver cancer	0.000108	0.000487	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—RAF1—liver cancer	0.000108	0.000486	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—TAT—liver cancer	0.000108	0.000485	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—HRAS—liver cancer	0.000108	0.000484	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—H2AFX—liver cancer	0.000107	0.00048	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—IL6—liver cancer	0.000107	0.00048	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—IL2—liver cancer	0.000107	0.00048	CbGpPWpGaD
Bupivacaine—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000106	0.000476	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PIK3CB—liver cancer	0.000106	0.000475	CbGpPWpGaD
Bupivacaine—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000104	0.000469	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—IL6—liver cancer	0.000103	0.000463	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000103	0.000462	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—UGDH—liver cancer	0.000103	0.000461	CbGpPWpGaD
Bupivacaine—SCN4A—Developmental Biology—AKT1—liver cancer	9.86e-05	0.000443	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL2—liver cancer	9.7e-05	0.000436	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TERT—liver cancer	9.67e-05	0.000434	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—EPT1—liver cancer	9.65e-05	0.000434	CbGpPWpGaD
Bupivacaine—SCN10A—Developmental Biology—AKT1—liver cancer	9.5e-05	0.000427	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—TAT—liver cancer	9.14e-05	0.000411	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	8.99e-05	0.000404	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—KDR—liver cancer	8.84e-05	0.000397	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MAPK14—liver cancer	8.78e-05	0.000395	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—liver cancer	8.64e-05	0.000388	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—ESR1—liver cancer	8.62e-05	0.000387	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—F2—liver cancer	8.51e-05	0.000382	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CG—liver cancer	8.14e-05	0.000366	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—APC—liver cancer	8.14e-05	0.000366	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CPT1B—liver cancer	7.98e-05	0.000359	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GLUL—liver cancer	7.98e-05	0.000359	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—UGDH—liver cancer	7.92e-05	0.000356	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NR1H4—liver cancer	7.69e-05	0.000346	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—BRAF—liver cancer	7.65e-05	0.000344	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTA3—liver cancer	7.56e-05	0.00034	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—EPT1—liver cancer	7.44e-05	0.000335	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CPT1B—liver cancer	7.34e-05	0.00033	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GLUL—liver cancer	7.34e-05	0.00033	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CD—liver cancer	7.16e-05	0.000322	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—PIK3CA—liver cancer	7.09e-05	0.000319	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—SERPINE1—liver cancer	7.08e-05	0.000318	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NR1H4—liver cancer	7.08e-05	0.000318	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—TAT—liver cancer	7.06e-05	0.000317	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—KRAS—liver cancer	7.01e-05	0.000315	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTA3—liver cancer	6.96e-05	0.000313	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTA4—liver cancer	6.92e-05	0.000311	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	6.76e-05	0.000304	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTA2—liver cancer	6.74e-05	0.000303	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—liver cancer	6.73e-05	0.000303	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTA1—liver cancer	6.5e-05	0.000292	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—PIK3CA—liver cancer	6.44e-05	0.000289	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—NAT2—liver cancer	6.43e-05	0.000289	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—RAF1—liver cancer	6.39e-05	0.000287	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTA4—liver cancer	6.36e-05	0.000286	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MTOR—liver cancer	6.24e-05	0.00028	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CB—liver cancer	6.24e-05	0.00028	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GLUL—liver cancer	6.22e-05	0.000279	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CPT1B—liver cancer	6.22e-05	0.000279	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTA2—liver cancer	6.2e-05	0.000279	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PPARA—liver cancer	6.18e-05	0.000278	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALDOB—liver cancer	6.16e-05	0.000277	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NR1H4—liver cancer	5.99e-05	0.000269	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTA1—liver cancer	5.98e-05	0.000269	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—HRAS—liver cancer	5.96e-05	0.000268	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—NAT2—liver cancer	5.91e-05	0.000266	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTA3—liver cancer	5.89e-05	0.000265	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CRABP1—liver cancer	5.88e-05	0.000264	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CDKN1B—liver cancer	5.86e-05	0.000263	CbGpPWpGaD
Bupivacaine—PTGER1—GPCR downstream signaling—AKT1—liver cancer	5.79e-05	0.00026	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CASP3—liver cancer	5.74e-05	0.000258	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL2—liver cancer	5.73e-05	0.000258	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—IL6—liver cancer	5.7e-05	0.000256	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALDOB—liver cancer	5.67e-05	0.000255	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CCND1—liver cancer	5.59e-05	0.000251	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—JUN—liver cancer	5.57e-05	0.000251	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CTNNB1—liver cancer	5.53e-05	0.000249	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MMP9—liver cancer	5.42e-05	0.000244	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CRABP1—liver cancer	5.41e-05	0.000243	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—CDKN1A—liver cancer	5.4e-05	0.000243	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTA4—liver cancer	5.39e-05	0.000242	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	5.3e-05	0.000238	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MAPK8—liver cancer	5.28e-05	0.000237	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	5.27e-05	0.000237	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling by GPCR—AKT1—liver cancer	5.26e-05	0.000236	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTA2—liver cancer	5.25e-05	0.000236	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HPGDS—liver cancer	5.14e-05	0.000231	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—liver cancer	5.11e-05	0.00023	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTA1—liver cancer	5.07e-05	0.000228	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—NAT2—liver cancer	5.01e-05	0.000225	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—VEGFA—liver cancer	4.87e-05	0.000219	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—STAT3—liver cancer	4.82e-05	0.000217	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—liver cancer	4.82e-05	0.000217	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALDOB—liver cancer	4.8e-05	0.000216	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CPT1B—liver cancer	4.8e-05	0.000216	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GLUL—liver cancer	4.8e-05	0.000216	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HPGDS—liver cancer	4.73e-05	0.000212	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	4.65e-05	0.000209	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NR1H4—liver cancer	4.63e-05	0.000208	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—liver cancer	4.6e-05	0.000207	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CRABP1—liver cancer	4.58e-05	0.000206	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PSMA4—liver cancer	4.58e-05	0.000206	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PSMD10—liver cancer	4.58e-05	0.000206	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTA3—liver cancer	4.55e-05	0.000204	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—MYC—liver cancer	4.48e-05	0.000201	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TGFB1—liver cancer	4.47e-05	0.000201	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GOT2—liver cancer	4.46e-05	0.0002	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PSMD10—liver cancer	4.21e-05	0.000189	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PSMA4—liver cancer	4.21e-05	0.000189	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP2E1—liver cancer	4.19e-05	0.000188	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTA4—liver cancer	4.16e-05	0.000187	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—KRAS—liver cancer	4.14e-05	0.000186	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	4.13e-05	0.000185	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GOT2—liver cancer	4.1e-05	0.000184	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	4.06e-05	0.000182	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTA2—liver cancer	4.05e-05	0.000182	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HPGDS—liver cancer	4.01e-05	0.00018	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—liver cancer	3.98e-05	0.000179	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYCS—liver cancer	3.92e-05	0.000176	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTA1—liver cancer	3.91e-05	0.000176	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—NAT2—liver cancer	3.87e-05	0.000174	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP2E1—liver cancer	3.85e-05	0.000173	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GGT1—liver cancer	3.85e-05	0.000173	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GOT1—liver cancer	3.85e-05	0.000173	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—PIK3CA—liver cancer	3.8e-05	0.000171	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALDOB—liver cancer	3.71e-05	0.000167	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—TP53—liver cancer	3.68e-05	0.000165	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	3.63e-05	0.000163	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYCS—liver cancer	3.61e-05	0.000162	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—liver cancer	3.58e-05	0.000161	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PSMA4—liver cancer	3.57e-05	0.00016	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PSMD10—liver cancer	3.57e-05	0.00016	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GGT1—liver cancer	3.54e-05	0.000159	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GOT1—liver cancer	3.54e-05	0.000159	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CRABP1—liver cancer	3.54e-05	0.000159	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—HRAS—liver cancer	3.52e-05	0.000158	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GOT2—liver cancer	3.47e-05	0.000156	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTP1—liver cancer	3.46e-05	0.000155	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—HMOX1—liver cancer	3.41e-05	0.000153	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—IL6—liver cancer	3.37e-05	0.000151	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP2E1—liver cancer	3.27e-05	0.000147	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTP1—liver cancer	3.18e-05	0.000143	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—GSTM1—liver cancer	3.18e-05	0.000143	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	3.16e-05	0.000142	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—HMOX1—liver cancer	3.13e-05	0.000141	CbGpPWpGaD
Bupivacaine—PTGER1—Signaling Pathways—AKT1—liver cancer	3.11e-05	0.00014	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HPGDS—liver cancer	3.09e-05	0.000139	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYCS—liver cancer	3.05e-05	0.000137	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—CYP1A1—liver cancer	3.01e-05	0.000135	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GGT1—liver cancer	3e-05	0.000135	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GOT1—liver cancer	3e-05	0.000135	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—GSTM1—liver cancer	2.92e-05	0.000131	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—MTHFR—liver cancer	2.81e-05	0.000126	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—CYP1A1—liver cancer	2.77e-05	0.000124	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PSMD10—liver cancer	2.76e-05	0.000124	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PSMA4—liver cancer	2.76e-05	0.000124	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PPARA—liver cancer	2.75e-05	0.000124	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTP1—liver cancer	2.69e-05	0.000121	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GOT2—liver cancer	2.68e-05	0.00012	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—HMOX1—liver cancer	2.66e-05	0.000119	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—MTHFR—liver cancer	2.58e-05	0.000116	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PPARA—liver cancer	2.53e-05	0.000114	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP2E1—liver cancer	2.52e-05	0.000113	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—GSTM1—liver cancer	2.47e-05	0.000111	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	2.47e-05	0.000111	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CG—liver cancer	2.36e-05	0.000106	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYCS—liver cancer	2.36e-05	0.000106	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—CYP1A1—liver cancer	2.35e-05	0.000105	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GOT1—liver cancer	2.31e-05	0.000104	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GGT1—liver cancer	2.31e-05	0.000104	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PPARG—liver cancer	2.28e-05	0.000102	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—MTHFR—liver cancer	2.19e-05	9.83e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CG—liver cancer	2.17e-05	9.75e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PPARA—liver cancer	2.15e-05	9.64e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PPARG—liver cancer	2.09e-05	9.41e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTP1—liver cancer	2.08e-05	9.34e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CD—liver cancer	2.07e-05	9.32e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—HMOX1—liver cancer	2.05e-05	9.21e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—ALB—liver cancer	2.05e-05	9.2e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	1.93e-05	8.66e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—GSTM1—liver cancer	1.91e-05	8.58e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CD—liver cancer	1.91e-05	8.57e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—ALB—liver cancer	1.88e-05	8.46e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CG—liver cancer	1.84e-05	8.26e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—CYP1A1—liver cancer	1.81e-05	8.14e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CB—liver cancer	1.81e-05	8.12e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PPARG—liver cancer	1.77e-05	7.97e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—MTHFR—liver cancer	1.69e-05	7.59e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CB—liver cancer	1.66e-05	7.47e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PPARA—liver cancer	1.66e-05	7.44e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CD—liver cancer	1.62e-05	7.26e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—ALB—liver cancer	1.59e-05	7.17e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CG—liver cancer	1.42e-05	6.37e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CB—liver cancer	1.41e-05	6.33e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PPARG—liver cancer	1.37e-05	6.15e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CD—liver cancer	1.25e-05	5.6e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—ALB—liver cancer	1.23e-05	5.53e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—PIK3CA—liver cancer	1.1e-05	4.95e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CB—liver cancer	1.09e-05	4.88e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—PIK3CA—liver cancer	1.01e-05	4.55e-05	CbGpPWpGaD
Bupivacaine—CYP2C19—Metabolism—AKT1—liver cancer	9e-06	4.04e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—PIK3CA—liver cancer	8.58e-06	3.86e-05	CbGpPWpGaD
Bupivacaine—CYP2D6—Metabolism—AKT1—liver cancer	8.28e-06	3.72e-05	CbGpPWpGaD
Bupivacaine—CYP1A2—Metabolism—AKT1—liver cancer	7.01e-06	3.15e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—PIK3CA—liver cancer	6.62e-06	2.98e-05	CbGpPWpGaD
Bupivacaine—CYP3A4—Metabolism—AKT1—liver cancer	5.41e-06	2.43e-05	CbGpPWpGaD
